Does diastolic dysfunction precede systolic dysfunction in trastuzumab-induced cardiotoxicity? Assessment with multigated radionuclide angiography (MUGA)

Autor: S. E. Elias-Smale, B.F. Bulten, E. J. Reuvekamp, L. F. de Geus-Oei, Jolien Tol, A. A. Nieuwenhuis, A. H. E. M. Maas, A. F. J. de Haan, M. R. A. Meekes

Publikováno v: Journal of Nuclear Cardiology, 23, pp. 824-832
Journal of nuclear cardiology, 23(4), 824-832. Springer
Journal of Nuclear Cardiology, 23, 824-832
Journal of Nuclear Cardiology
Journal of Nuclear Cardiology, 23(4), 824-832

Contains fulltext : 165961.pdf (Publisher’s version ) (Open Access) Trastuzumab is successfully used for the treatment of HER2-positive breast cancer. Because of its association with cardiotoxicity, LVEF is monitored by MUGA, though this is a relat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c441e1927b1cf604e801348843cdce3b
https://hdl.handle.net/2066/165961